| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.37e-05 | 27 | 126 | 4 | GO:0004683 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 2.50e-05 | 55 | 126 | 5 | GO:0017046 | |
| GeneOntologyMolecularFunction | hormone binding | 4.86e-05 | 103 | 126 | 6 | GO:0042562 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.07e-04 | 230 | 126 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor activity | 1.18e-04 | 3 | 126 | 2 | GO:0043404 | |
| GeneOntologyMolecularFunction | corticotrophin-releasing factor receptor activity | 1.18e-04 | 3 | 126 | 2 | GO:0015056 | |
| GeneOntologyMolecularFunction | glucagon receptor activity | 1.18e-04 | 3 | 126 | 2 | GO:0004967 | |
| GeneOntologyMolecularFunction | carbon-sulfur lyase activity | 1.29e-04 | 16 | 126 | 3 | GO:0016846 | |
| GeneOntologyMolecularFunction | protein-phosphatidylethanolamide deconjugating activity | 2.35e-04 | 4 | 126 | 2 | GO:0019786 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.96e-04 | 23 | 126 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | helicase activity | 5.03e-04 | 158 | 126 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 5.10e-04 | 25 | 126 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | CHD2 VARS2 SRCAP TERF1 IFIH1 PSTK TRMT44 NYNRIN HLTF DDX21 MOV10 DNMT3L | 7.93e-04 | 645 | 126 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | cadherin binding | 1.41e-03 | 339 | 126 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.56e-03 | 133 | 126 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.63e-03 | 37 | 126 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 1.72e-03 | 10 | 126 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.95e-03 | 140 | 126 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.09e-03 | 11 | 126 | 2 | GO:0098973 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | HFE KLHL24 CAMK2A CAMK2B CAMK2D CAMK2G CRHR1 CRHR2 SPTBN4 TMEM168 GLP1R ATP1A1 | 3.65e-05 | 493 | 122 | 12 | GO:0010959 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | HFE KLHL24 CAMK2A CAMK2B CAMK2D CAMK2G GRIN2C CRHR1 CRHR2 SPTBN4 TMEM168 GLP1R ATP1A1 | 3.80e-05 | 577 | 122 | 13 | GO:0043269 |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 5.68e-09 | 5 | 123 | 4 | GO:0005954 | |
| Domain | CaMKII_AD | 1.85e-09 | 4 | 124 | 4 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 1.85e-09 | 4 | 124 | 4 | IPR013543 | |
| Domain | HormR | 5.68e-07 | 25 | 124 | 5 | SM00008 | |
| Domain | HRM | 1.03e-06 | 28 | 124 | 5 | PF02793 | |
| Domain | - | 1.26e-06 | 13 | 124 | 4 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 2.39e-06 | 15 | 124 | 4 | IPR032710 | |
| Domain | GPCR_2_secretin-like_CS | 2.84e-06 | 34 | 124 | 5 | IPR017983 | |
| Domain | GPCR_2_extracellular_dom | 6.50e-06 | 40 | 124 | 5 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 6.50e-06 | 40 | 124 | 5 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 6.50e-06 | 40 | 124 | 5 | PS50227 | |
| Domain | 7tm_2 | 1.98e-05 | 50 | 124 | 5 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.98e-05 | 50 | 124 | 5 | PS00650 | |
| Domain | IQ_motif_EF-hand-BS | 2.99e-05 | 90 | 124 | 6 | IPR000048 | |
| Domain | IQ | 3.61e-05 | 93 | 124 | 6 | PS50096 | |
| Domain | LMF | 4.37e-05 | 2 | 124 | 2 | IPR009613 | |
| Domain | GPCR_2_GLP1/glucagon_rcpt | 4.37e-05 | 2 | 124 | 2 | IPR003290 | |
| Domain | LMF1 | 4.37e-05 | 2 | 124 | 2 | PF06762 | |
| Domain | ANK | 4.59e-05 | 251 | 124 | 9 | SM00248 | |
| Domain | GPCR_2_secretin-like | 4.85e-05 | 60 | 124 | 5 | IPR000832 | |
| Domain | GPCR_2-like | 4.85e-05 | 60 | 124 | 5 | IPR017981 | |
| Domain | ANK_REPEAT | 4.88e-05 | 253 | 124 | 9 | PS50088 | |
| Domain | ANK_REP_REGION | 5.03e-05 | 254 | 124 | 9 | PS50297 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 5.26e-05 | 61 | 124 | 5 | PS50261 | |
| Domain | Ankyrin_rpt | 6.39e-05 | 262 | 124 | 9 | IPR002110 | |
| Domain | Ank_2 | 9.50e-05 | 215 | 124 | 8 | PF12796 | |
| Domain | GPCR_2_CRF_rcpt | 1.31e-04 | 3 | 124 | 2 | IPR003051 | |
| Domain | Ank | 1.43e-04 | 228 | 124 | 8 | PF00023 | |
| Domain | IQ | 2.04e-04 | 81 | 124 | 5 | SM00015 | |
| Domain | - | 2.53e-04 | 248 | 124 | 8 | 1.25.40.20 | |
| Domain | DCB_dom | 2.60e-04 | 4 | 124 | 2 | IPR032629 | |
| Domain | Peptidase_C54 | 2.60e-04 | 4 | 124 | 2 | PF03416 | |
| Domain | Sec7_C | 2.60e-04 | 4 | 124 | 2 | IPR015403 | |
| Domain | DUF1981 | 2.60e-04 | 4 | 124 | 2 | PF09324 | |
| Domain | Peptidase_C54 | 2.60e-04 | 4 | 124 | 2 | IPR005078 | |
| Domain | Sec7_N | 2.60e-04 | 4 | 124 | 2 | IPR032691 | |
| Domain | Sec7_N | 2.60e-04 | 4 | 124 | 2 | PF12783 | |
| Domain | DCB | 2.60e-04 | 4 | 124 | 2 | PF16213 | |
| Domain | Ankyrin_rpt-contain_dom | 2.97e-04 | 254 | 124 | 8 | IPR020683 | |
| Domain | NUT | 4.32e-04 | 5 | 124 | 2 | IPR024310 | |
| Domain | NUT_N | 4.32e-04 | 5 | 124 | 2 | IPR024309 | |
| Domain | NUT | 4.32e-04 | 5 | 124 | 2 | PF12881 | |
| Domain | INTEGRASE | 4.32e-04 | 5 | 124 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 4.32e-04 | 5 | 124 | 2 | IPR001584 | |
| Domain | Helicase_C | 7.37e-04 | 107 | 124 | 5 | PF00271 | |
| Domain | HELICc | 7.37e-04 | 107 | 124 | 5 | SM00490 | |
| Domain | Helicase_C | 7.69e-04 | 108 | 124 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 8.01e-04 | 109 | 124 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 8.01e-04 | 109 | 124 | 5 | PS51192 | |
| Domain | DEXDc | 8.01e-04 | 109 | 124 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 8.35e-04 | 110 | 124 | 5 | IPR014001 | |
| Domain | SWIM | 8.98e-04 | 7 | 124 | 2 | PF04434 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.15e-03 | 69 | 124 | 4 | IPR020636 | |
| Domain | SNF2_N | 1.23e-03 | 32 | 124 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.23e-03 | 32 | 124 | 3 | PF00176 | |
| Domain | IQ | 1.28e-03 | 71 | 124 | 4 | PF00612 | |
| Domain | ZF_SWIM | 1.53e-03 | 9 | 124 | 2 | PS50966 | |
| Domain | Znf_SWIM | 1.53e-03 | 9 | 124 | 2 | IPR007527 | |
| Domain | - | 4.34e-03 | 15 | 124 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 4.34e-03 | 15 | 124 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.34e-03 | 15 | 124 | 2 | IPR023394 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 4.34e-03 | 15 | 124 | 2 | IPR009080 | |
| Domain | SEC7 | 4.94e-03 | 16 | 124 | 2 | PS50190 | |
| Domain | Sec7 | 4.94e-03 | 16 | 124 | 2 | SM00222 | |
| Domain | Sec7_dom | 4.94e-03 | 16 | 124 | 2 | IPR000904 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.50e-07 | 21 | 87 | 5 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.50e-07 | 21 | 87 | 5 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.93e-07 | 22 | 87 | 5 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 2.46e-07 | 23 | 87 | 5 | M27949 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.76e-07 | 10 | 87 | 4 | M26910 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 3.09e-07 | 24 | 87 | 5 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 3.09e-07 | 24 | 87 | 5 | M39643 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.84e-07 | 25 | 87 | 5 | M47511 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.29e-06 | 14 | 87 | 4 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.29e-06 | 14 | 87 | 4 | M47388 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.41e-06 | 32 | 87 | 5 | M27900 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.65e-06 | 33 | 87 | 5 | M39875 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.75e-06 | 15 | 87 | 4 | M47385 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.24e-06 | 35 | 87 | 5 | MM15109 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 3.03e-06 | 17 | 87 | 4 | M47387 | |
| Pathway | PID_IFNG_PATHWAY | 4.43e-06 | 40 | 87 | 5 | M161 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 4.89e-06 | 19 | 87 | 4 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 4.89e-06 | 19 | 87 | 4 | MM15473 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 6.08e-06 | 20 | 87 | 4 | M17670 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.16e-06 | 44 | 87 | 5 | M27934 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 9.97e-06 | 47 | 87 | 5 | M39531 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.10e-05 | 23 | 87 | 4 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.10e-05 | 23 | 87 | 4 | M47512 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.31e-05 | 24 | 87 | 4 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.55e-05 | 25 | 87 | 4 | M47510 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.99e-05 | 54 | 87 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.99e-05 | 54 | 87 | 5 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.18e-05 | 55 | 87 | 5 | M971 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.47e-05 | 28 | 87 | 4 | M837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.47e-05 | 28 | 87 | 4 | M47508 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.59e-05 | 57 | 87 | 5 | MM15643 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.86e-05 | 29 | 87 | 4 | MM15028 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.33e-05 | 60 | 87 | 5 | MM14964 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.75e-05 | 31 | 87 | 4 | M7223 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 4.23e-05 | 63 | 87 | 5 | M27862 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 4.26e-05 | 32 | 87 | 4 | M27455 | |
| Pathway | REACTOME_RAF_ACTIVATION | 5.45e-05 | 34 | 87 | 4 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 6.12e-05 | 35 | 87 | 4 | MM15271 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 6.92e-05 | 113 | 87 | 6 | M16817 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 7.04e-05 | 70 | 87 | 5 | M3115 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 7.65e-05 | 37 | 87 | 4 | M749 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 8.51e-05 | 38 | 87 | 4 | M27255 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.06e-04 | 176 | 87 | 7 | MM15718 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.15e-04 | 41 | 87 | 4 | M512 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.35e-04 | 183 | 87 | 7 | M997 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.52e-04 | 44 | 87 | 4 | M39845 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.66e-04 | 45 | 87 | 4 | M27623 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.57e-04 | 92 | 87 | 5 | MM14951 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.84e-04 | 94 | 87 | 5 | M2843 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 2.84e-04 | 94 | 87 | 5 | M797 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.38e-04 | 54 | 87 | 4 | M26911 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 3.45e-04 | 98 | 87 | 5 | M965 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.97e-04 | 101 | 87 | 5 | M27253 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 3.97e-04 | 101 | 87 | 5 | M1979 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.34e-04 | 103 | 87 | 5 | MM15196 | |
| Pathway | KEGG_GLIOMA | 6.88e-04 | 65 | 87 | 4 | M1835 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 6.88e-04 | 65 | 87 | 4 | M38994 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO4 HFE LMF1 CAMK2A CAMK2B CAMK2D CAMK2G EIF2S3B LMF2 EIF2S3 TRPV6 ATP1A1 | 9.34e-04 | 681 | 87 | 12 | MM14985 |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 9.89e-04 | 32 | 87 | 3 | M48012 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 1.03e-03 | 8 | 87 | 2 | M10546 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | CAMK2A CAMK2B CAMK2D CAMK2G EIF2S3B TERF1 AAAS EIF2S3 ANAPC2 MIOS | 1.07e-03 | 505 | 87 | 10 | MM15548 |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.08e-03 | 33 | 87 | 3 | MM15066 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.08e-03 | 33 | 87 | 3 | M10322 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.08e-03 | 126 | 87 | 5 | M16763 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.18e-03 | 75 | 87 | 4 | M39568 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.25e-03 | 130 | 87 | 5 | M27454 | |
| Pathway | REACTOME_RECYCLING_OF_EIF2_GDP | 1.32e-03 | 9 | 87 | 2 | MM15418 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.48e-03 | 273 | 87 | 7 | M983 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS | 1.64e-03 | 10 | 87 | 2 | MM17234 | |
| Pathway | BIOCARTA_EIF_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1394 | |
| Pathway | BIOCARTA_EIF2_PATHWAY | 1.64e-03 | 10 | 87 | 2 | MM1469 | |
| Pathway | WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1 | 1.64e-03 | 10 | 87 | 2 | M45510 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.64e-03 | 82 | 87 | 4 | M27626 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.73e-03 | 140 | 87 | 5 | M42572 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.90e-03 | 143 | 87 | 5 | MM15055 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.96e-03 | 144 | 87 | 5 | MM14501 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 2.00e-03 | 11 | 87 | 2 | MM15559 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.04e-03 | 87 | 87 | 4 | M12467 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.31e-03 | 90 | 87 | 4 | M6467 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 2.31e-03 | 90 | 87 | 4 | M820 | |
| Pathway | REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR | 2.39e-03 | 12 | 87 | 2 | MM14981 | |
| Pathway | WP_ERBB_SIGNALING | 2.50e-03 | 92 | 87 | 4 | M39715 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.62e-03 | 154 | 87 | 5 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.77e-03 | 156 | 87 | 5 | M39475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION | 2.81e-03 | 13 | 87 | 2 | M47458 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.85e-03 | 157 | 87 | 5 | M4904 | |
| Pathway | KEGG_MELANOGENESIS | 3.51e-03 | 101 | 87 | 4 | M7761 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.53e-03 | 165 | 87 | 5 | MM15026 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 3.75e-03 | 15 | 87 | 2 | M953 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE | 4.27e-03 | 16 | 87 | 2 | M47871 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING | 4.27e-03 | 16 | 87 | 2 | M47476 | |
| Pubmed | 1.98e-10 | 4 | 132 | 4 | 10381553 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 1.98e-10 | 4 | 132 | 4 | 17367784 | |
| Pubmed | 1.98e-10 | 4 | 132 | 4 | 11889801 | ||
| Pubmed | 5.66e-10 | 12 | 132 | 5 | 8665664 | ||
| Pubmed | 5.66e-10 | 12 | 132 | 5 | 12815021 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 11013247 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 18218981 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 21209221 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 14722083 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 9.88e-10 | 5 | 132 | 4 | 16436603 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 2.96e-09 | 6 | 132 | 4 | 18948074 | |
| Pubmed | 6.88e-09 | 7 | 132 | 4 | 15276201 | ||
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 6.88e-09 | 7 | 132 | 4 | 9115241 | |
| Pubmed | 1.37e-08 | 8 | 132 | 4 | 12475935 | ||
| Pubmed | 1.37e-08 | 8 | 132 | 4 | 11264466 | ||
| Pubmed | 1.37e-08 | 8 | 132 | 4 | 20668654 | ||
| Pubmed | 2.46e-08 | 9 | 132 | 4 | 12660151 | ||
| Pubmed | 2.46e-08 | 9 | 132 | 4 | 16364570 | ||
| Pubmed | 4.09e-08 | 10 | 132 | 4 | 28361052 | ||
| Pubmed | 4.09e-08 | 10 | 132 | 4 | 19776387 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 5.34e-08 | 3 | 132 | 3 | 9060999 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 10819240 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 20844140 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 9882483 | ||
| Pubmed | 9.58e-08 | 12 | 132 | 4 | 8615909 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 10373510 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 2.62e-07 | 15 | 132 | 4 | 14622581 | |
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 9481670 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 11160423 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 19671701 | ||
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 5.31e-07 | 5 | 132 | 3 | 28636948 | |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 5.82e-07 | 18 | 132 | 4 | 18311135 | |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 16120608 | ||
| Pubmed | Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow. | 1.06e-06 | 6 | 132 | 3 | 27250503 | |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 17171436 | ||
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 1.06e-06 | 6 | 132 | 3 | 11972023 | |
| Pubmed | A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. | 1.06e-06 | 6 | 132 | 3 | 20877009 | |
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 34932950 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CAMK2A CAMK2B CAMK2G CNTNAP1 NIPSNAP1 EIF2S3B NDUFA13 EIF2S3 ATP1A1 GNL1 CCDC9 PACSIN2 | 4.71e-06 | 621 | 132 | 12 | 22794259 |
| Pubmed | 6.29e-06 | 10 | 132 | 3 | 19332541 | ||
| Pubmed | 6.29e-06 | 10 | 132 | 3 | 15670850 | ||
| Pubmed | 6.64e-06 | 341 | 132 | 9 | 29791485 | ||
| Pubmed | 7.25e-06 | 70 | 132 | 5 | 12036966 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 21491429 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37701987 | ||
| Pubmed | Expression and subcellular localization of CRH and its receptors in human endometrial cancer. | 1.43e-05 | 2 | 132 | 2 | 19433256 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15294044 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21884935 | ||
| Pubmed | Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. | 1.43e-05 | 2 | 132 | 2 | 19098121 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33369025 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 7613039 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20594969 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37543650 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32149607 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 38597448 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23203689 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25650780 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22467522 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27496951 | ||
| Pubmed | Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice. | 1.43e-05 | 2 | 132 | 2 | 19602537 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27226600 | ||
| Pubmed | Alterations of L-type calcium current and cardiac function in CaMKII{delta} knockout mice. | 1.43e-05 | 2 | 132 | 2 | 20538682 | |
| Pubmed | CaMK-II oligomerization potential determined using CFP/YFP FRET. | 1.43e-05 | 2 | 132 | 2 | 16185778 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18703025 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17184923 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 9523577 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31844086 | ||
| Pubmed | Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance. | 1.43e-05 | 2 | 132 | 2 | 34303021 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17170072 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 14724656 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11710563 | ||
| Pubmed | Joint effect of RRP9 and DDX21 on development of colorectal cancer and keloid. | 1.43e-05 | 2 | 132 | 2 | 37988222 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23918382 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17959885 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18325997 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17532191 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37904456 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12110614 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23177644 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32057826 | ||
| Pubmed | Identification of Nipsnap1 as a novel auxiliary protein inhibiting TRPV6 activity. | 1.43e-05 | 2 | 132 | 2 | 18392847 | |
| Pubmed | Distinct distribution of corticotropin releasing factor receptors in human breast cancer. | 1.43e-05 | 2 | 132 | 2 | 20630588 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34908526 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10693762 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17360629 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10716990 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28253956 | ||
| Pubmed | De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability. | 1.43e-05 | 2 | 132 | 2 | 29100089 | |
| Pubmed | Effect of CRHR1 and CRHR2 gene polymorphisms and childhood trauma in suicide attempt. | 1.43e-05 | 2 | 132 | 2 | 30874897 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24465390 | ||
| Pubmed | CaMKII is essential for the function of the enteric nervous system. | 1.43e-05 | 2 | 132 | 2 | 22952977 | |
| Pubmed | Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery. | 1.43e-05 | 2 | 132 | 2 | 33920024 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21252154 | ||
| Pubmed | Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. | 1.43e-05 | 2 | 132 | 2 | 17994020 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18203920 | ||
| Pubmed | Differential effects of oxyntomodulin and GLP-1 on glucose metabolism. | 1.43e-05 | 2 | 132 | 2 | 22621866 | |
| Pubmed | Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells. | 1.43e-05 | 2 | 132 | 2 | 21871176 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31619570 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29992531 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 9105899 | ||
| Interaction | CAMK2N1 interactions | 3.07e-07 | 10 | 127 | 4 | int:CAMK2N1 | |
| Interaction | POTED interactions | 9.73e-07 | 4 | 127 | 3 | int:POTED | |
| Interaction | POTEC interactions | 1.03e-06 | 13 | 127 | 4 | int:POTEC | |
| Interaction | CIBAR2 interactions | 8.40e-06 | 7 | 127 | 3 | int:CIBAR2 | |
| Interaction | CAMK2N2 interactions | 8.40e-06 | 7 | 127 | 3 | int:CAMK2N2 | |
| Interaction | PDE4A interactions | 3.63e-05 | 30 | 127 | 4 | int:PDE4A | |
| Interaction | POTEG interactions | 5.16e-05 | 12 | 127 | 3 | int:POTEG | |
| Interaction | TTC5 interactions | 5.60e-05 | 65 | 127 | 5 | int:TTC5 | |
| Cytoband | 3p21.2 | 2.18e-05 | 19 | 132 | 3 | 3p21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 3.28e-05 | 208 | 132 | 6 | chr10q22 | |
| Cytoband | Xp11.22 | 5.18e-04 | 54 | 132 | 3 | Xp11.22 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 5.41e-12 | 13 | 72 | 6 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 5.25e-06 | 242 | 72 | 8 | 403 | |
| GeneFamily | Corticotropin releasing hormone receptors | 1.56e-05 | 2 | 72 | 2 | 266 | |
| GeneFamily | Glucagon receptor family | 2.32e-04 | 6 | 72 | 2 | 269 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 5.53e-04 | 9 | 72 | 2 | 90 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.19e-03 | 13 | 72 | 2 | 1186 | |
| Coexpression | GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN | 6.67e-06 | 199 | 129 | 8 | M3286 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.80e-06 | 193 | 132 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-05 | 171 | 132 | 6 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-05 | 173 | 132 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 176 | 132 | 6 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 176 | 132 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 176 | 132 | 6 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 176 | 132 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 186 | 132 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.08e-05 | 188 | 132 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.27e-05 | 191 | 132 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-05 | 192 | 132 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.41e-05 | 193 | 132 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 194 | 132 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.48e-05 | 194 | 132 | 6 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 195 | 132 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.55e-05 | 195 | 132 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 197 | 132 | 6 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.78e-05 | 198 | 132 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.78e-05 | 198 | 132 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.86e-05 | 199 | 132 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.94e-05 | 200 | 132 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.33e-05 | 136 | 132 | 5 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.33e-05 | 136 | 132 | 5 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.96e-05 | 148 | 132 | 5 | 1186ee0d15244fee74c1d09df3967c1b69f8ddce | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.31e-05 | 153 | 132 | 5 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.31e-05 | 153 | 132 | 5 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.31e-05 | 153 | 132 | 5 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-04 | 157 | 132 | 5 | 0551442ae14685d8fe5729e3960c6324b1e05e4d | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-04 | 157 | 132 | 5 | 803af734d7f775d294391e2b84e472a732e18cef | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-04 | 157 | 132 | 5 | 9aa5304a9704da6dd4eda7d6940494b00e38b2e8 | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.12e-04 | 159 | 132 | 5 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 1.12e-04 | 159 | 132 | 5 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.18e-04 | 161 | 132 | 5 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 161 | 132 | 5 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-04 | 163 | 132 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 167 | 132 | 5 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.44e-04 | 168 | 132 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.48e-04 | 169 | 132 | 5 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 171 | 132 | 5 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 171 | 132 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 174 | 132 | 5 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 174 | 132 | 5 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.79e-04 | 176 | 132 | 5 | 8e0ac3ad5e47614b4befabd674a40e3eaae553f3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.84e-04 | 177 | 132 | 5 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 177 | 132 | 5 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.94e-04 | 179 | 132 | 5 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 180 | 132 | 5 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 1.99e-04 | 180 | 132 | 5 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 181 | 132 | 5 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 183 | 132 | 5 | b60638680b1882b5a47f5dbce08f545e93bb4d0f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-04 | 185 | 132 | 5 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.26e-04 | 185 | 132 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 186 | 132 | 5 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 187 | 132 | 5 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 187 | 132 | 5 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 187 | 132 | 5 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-04 | 188 | 132 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.43e-04 | 188 | 132 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 2.43e-04 | 188 | 132 | 5 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 189 | 132 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.49e-04 | 189 | 132 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.55e-04 | 190 | 132 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-04 | 190 | 132 | 5 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-04 | 190 | 132 | 5 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 190 | 132 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-04 | 190 | 132 | 5 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.55e-04 | 190 | 132 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-04 | 190 | 132 | 5 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 190 | 132 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 191 | 132 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-04 | 191 | 132 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.62e-04 | 191 | 132 | 5 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-04 | 191 | 132 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.68e-04 | 192 | 132 | 5 | 185dd150d3345cd29625052a46f3ed89f2a9a8f6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 192 | 132 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 192 | 132 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 18-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 2.68e-04 | 192 | 132 | 5 | 9fae988ecd2ef1231bfd42a678a4903517694cbe | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-04 | 192 | 132 | 5 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 192 | 132 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.68e-04 | 192 | 132 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-04 | 192 | 132 | 5 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-04 | 192 | 132 | 5 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.75e-04 | 193 | 132 | 5 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-04 | 193 | 132 | 5 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 193 | 132 | 5 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-04 | 193 | 132 | 5 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-04 | 193 | 132 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 194 | 132 | 5 | 1531dcace28a14bd700e909a027426a8cee20337 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-04 | 194 | 132 | 5 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.81e-04 | 194 | 132 | 5 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 194 | 132 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.81e-04 | 194 | 132 | 5 | 40c7f9bd69a8e843b81972e25a67f591021415dd | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-04 | 194 | 132 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.81e-04 | 194 | 132 | 5 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 194 | 132 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.88e-04 | 195 | 132 | 5 | 51e6cfecd66a874673d0b79a295489a358bddfd5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-04 | 195 | 132 | 5 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-04 | 195 | 132 | 5 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-04 | 195 | 132 | 5 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| Drug | Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; HL60; HG-U133A | 1.66e-07 | 199 | 126 | 10 | 1739_DN | |
| Disease | heart conduction disease (implicated_via_orthology) | 8.01e-06 | 32 | 118 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | aminoacylase-1 measurement | 1.59e-05 | 2 | 118 | 2 | EFO_0020141 | |
| Disease | functional colonic disease (biomarker_via_orthology) | 4.74e-05 | 3 | 118 | 2 | DOID:3877 (biomarker_via_orthology) | |
| Disease | achalasia (is_implicated_in) | 9.46e-05 | 4 | 118 | 2 | DOID:9164 (is_implicated_in) | |
| Disease | Endometrial Stromal Sarcoma | 1.57e-04 | 5 | 118 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 2.35e-04 | 6 | 118 | 2 | C0334488 | |
| Disease | hypopituitarism (implicated_via_orthology) | 2.35e-04 | 6 | 118 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 3.29e-04 | 7 | 118 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | hippocampal CA3 volume | 4.04e-04 | 36 | 118 | 3 | EFO_0009395 | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 4.37e-04 | 8 | 118 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | leukodystrophy (implicated_via_orthology) | 5.60e-04 | 9 | 118 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | vascular brain injury measurement, vascular brain injury | 1.20e-03 | 13 | 118 | 2 | EFO_0006791, EFO_0006800 | |
| Disease | N-acetylglutamine measurement | 1.20e-03 | 13 | 118 | 2 | EFO_0800017 | |
| Disease | Cocaine-Related Disorders | 1.27e-03 | 117 | 118 | 4 | C0236736 | |
| Disease | Cocaine Abuse | 1.72e-03 | 127 | 118 | 4 | C0009171 | |
| Disease | Intellectual Disability | 2.18e-03 | 447 | 118 | 7 | C3714756 | |
| Disease | Anorexia | 2.33e-03 | 18 | 118 | 2 | C0003123 | |
| Disease | gestational age | 2.33e-03 | 138 | 118 | 4 | EFO_0005112 | |
| Disease | Cocaine Dependence | 2.39e-03 | 139 | 118 | 4 | C0600427 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 2.59e-03 | 19 | 118 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Osteoarthritis of hip | 2.87e-03 | 20 | 118 | 2 | C0029410 | |
| Disease | Major Depressive Disorder | 2.99e-03 | 243 | 118 | 5 | C1269683 | |
| Disease | Unipolar Depression | 3.92e-03 | 259 | 118 | 5 | C0041696 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRIANEWEEWRRRKE | 91 | Q96CN4 | |
| WRRAEGQAEWRAAQK | 311 | Q6UXG8 | |
| HHREQVWKRCINIWR | 71 | Q9NRG9 | |
| ICRHLGRDWSWEKQK | 91 | Q8WYN0 | |
| RAWTVVRHDRLWTTR | 621 | P78357 | |
| RDWRWVLLRLHKAGA | 141 | Q96AK3 | |
| LREFHKWIERVVGWL | 286 | Q9UJX6 | |
| VRVWSNIPAIRSRHW | 321 | Q9UJW3 | |
| EHIRWNTKWRRAIPD | 346 | Q9Y574 | |
| RLQWSRIWEVIGDHF | 1181 | Q9Y6D6 | |
| RIRLQWSRIWHVIGD | 1126 | Q9Y6D5 | |
| GSHAAAKRWLGRWRR | 46 | A0A0U1RR11 | |
| IQNWWTRRKVRQEHG | 671 | Q32M45 | |
| RHRWQGLVDTWKALK | 341 | Q9P1Z9 | |
| ARSKRWLKIIWRRHG | 81 | Q6IC83 | |
| DTWAAALRIQKVWRR | 206 | Q86XH1 | |
| ALVCRHLGRDWRWTQ | 86 | Q9Y4P1 | |
| HLGRDWRWTQRKRQP | 91 | Q9Y4P1 | |
| NKTRILRLWAAWGEE | 106 | A6NK89 | |
| QAWWRGTLVRRALLH | 76 | Q8N6M8 | |
| RLWRWHKSRLLQASE | 716 | Q9Y5H2 | |
| GWRLGWILIHDRRDI | 286 | P17735 | |
| GTRWISWRNRHGKQV | 126 | Q16832 | |
| LEFRKSWERWRLEHL | 411 | P43220 | |
| SWERWRLEHLHIQRD | 416 | P43220 | |
| IHLLGLRVDWDDRWI | 881 | P05023 | |
| PGIHAWQWSRELKLR | 776 | Q5VYM1 | |
| GHWLDKLRREWQMER | 86 | Q53F39 | |
| RQRFWRHWLVTDIKG | 106 | Q96S96 | |
| ILWGRIVNEWEDVRK | 136 | O60447 | |
| EEHWQRHLARTTGRW | 536 | O60447 | |
| GHWSIMKWNRERRRL | 46 | Q9P0J0 | |
| RQHMRWLWDIGGRKS | 2096 | Q5H8C1 | |
| HRWRLGKVLWEERNT | 416 | P47871 | |
| RWQIWLAAERSRDQR | 576 | Q9H7Z3 | |
| LAAERSRDQRHWRPW | 581 | Q9H7Z3 | |
| VRSAVRKRWHRWQDH | 366 | Q13324 | |
| RHVPLRRRSEWKWAA | 426 | Q7Z3B3 | |
| RRRSEWKWAADRAAI | 431 | Q7Z3B3 | |
| DVGRRRKHQSWWQAL | 1181 | Q86UK5 | |
| FEHNLETWRQLWRVL | 171 | P36915 | |
| IEWLKQHRNTIREWF | 936 | Q07075 | |
| DARIFKAWAVARGRW | 56 | Q92985 | |
| VWTLLHIRSAAERWK | 226 | Q8NGQ2 | |
| RAWPTKLEWERHKIR | 161 | Q30201 | |
| REKRGPLWRHWRRET | 26 | Q68DD2 | |
| VLEDGRQWWKLRSRS | 521 | Q9H6S3 | |
| RREDLDKLHRAAWWG | 136 | A0JP26 | |
| TVHWLREEAERGVLW | 5401 | Q5VST9 | |
| WVSNKWLHERGQEFR | 511 | P13674 | |
| RWQGWHSSERALERV | 406 | Q96JP2 | |
| EWARRWRQLVEKGPQ | 61 | Q9UNF0 | |
| RGHSRWFWLVRVLLS | 46 | Q1HG44 | |
| TDKREWWTGRLALDH | 1771 | Q14674 | |
| IWIRVASLNKGRWRH | 386 | Q6TFL4 | |
| GRQRKLWKDEGRWEH | 206 | O15234 | |
| EKIMDWRPRHLTRWN | 1506 | Q9P2K1 | |
| GSHAAAKRWLGRWRR | 46 | P0DPI3 | |
| VSARDWLTRRNGKQW | 191 | Q6P2I3 | |
| SDQEHIKLWRRNLWI | 1521 | O14647 | |
| RHRKPTGQWRREWDA | 281 | Q9Y3X0 | |
| HSDRRILWITLRTWK | 866 | Q8NCU4 | |
| LGAQRERWETFRKLW | 96 | A0A0U1RRI6 | |
| ARGRVAHLIEWKGWS | 106 | Q96AQ9 | |
| WHLGWTREFVEALRR | 71 | Q9BYX4 | |
| NSEVRSAIRKRWHRW | 396 | P34998 | |
| RWHRWQDKHSIRARV | 406 | P34998 | |
| EWVARRAVKALWNLR | 326 | Q92611 | |
| QAWWRGTLVRRTLLH | 51 | Q8IXL9 | |
| HKLTRDQWEDRIQVW | 161 | P15311 | |
| GVKHIARALRNVWQW | 176 | Q5T1A1 | |
| KPFIDREWWHRTIQR | 606 | Q14527 | |
| RVEKHWRLIGWGQIR | 446 | Q2VIR3 | |
| EEQRILNRSKRGWVW | 51 | P55286 | |
| TEIQEKWHDSRRWQL | 691 | Q9NR30 | |
| VRGNWQRWLKVRDLT | 1856 | Q7Z5N4 | |
| RQAWEAGRTRKEEAW | 866 | Q9UPN4 | |
| SEELKWWHERARLRS | 586 | Q3KP66 | |
| RSHLRVKRGWVWNQF | 36 | Q9H159 | |
| IRRKAGASWQDETRW | 26 | C9J302 | |
| ETRVWHRRDGKWLNV | 531 | Q13555 | |
| ETRVWHRRDGKWQNV | 451 | Q13557 | |
| VAEARTWHREGRWRV | 3916 | P98161 | |
| TWHREGRWRVLRLGA | 3921 | P98161 | |
| EGRRVSKAWLIRWSL | 1246 | Q9P2P1 | |
| RELEIGVHWRDWRQL | 366 | Q6P5Z2 | |
| VRREDLGKLHRAAWW | 61 | Q6S8J7 | |
| RREDLDKLHRAAWWG | 136 | B2RU33 | |
| AWKHEWLERRNRRGP | 196 | Q13233 | |
| LEEGLWRAMREWQHT | 376 | Q8IVF1 | |
| LEEGLWRAMREWQHT | 376 | A6NNL0 | |
| LEEGLWRAMREWQHT | 376 | B1AL46 | |
| TRNAAWRKRGWDENV | 246 | Q9BPW8 | |
| RREDLDKLHRAAWWG | 136 | Q86YR6 | |
| VNKHWDVRIDSKAWR | 21 | Q9UJJ7 | |
| LGRLVTRKSWLWQHD | 76 | P82930 | |
| LVRWHRMRGDQVLWV | 166 | Q5ST30 | |
| QSEETRVWHRRDGKW | 636 | Q13554 | |
| RVWHRRDGKWQNVHF | 641 | Q13554 | |
| RVHIRDWREETLWKT | 686 | Q8IYL2 | |
| RWTQVRGWLRKLSAV | 386 | Q9BU23 | |
| VQHRALELTGRWLLW | 456 | Q9HCE1 | |
| RLVDDRWLWRHVDLT | 36 | Q9NXK8 | |
| VGHEVLRQRKNWWKD | 366 | Q9NXP7 | |
| WRAAAALRLWGRVVE | 6 | Q9NTG7 | |
| RREDLDKLHRAAWWG | 136 | P0CG38 | |
| GHRVWRAEGLRALWK | 56 | Q8WUT9 | |
| ETRVWHRRDGKWQIV | 451 | Q9UQM7 | |
| WLSADFAQERRWKRG | 146 | Q6ZRS2 | |
| GAWRRDIFGRIIWHK | 166 | Q9HD33 | |
| EPHWWTRKRFGIVRL | 286 | Q7LFX5 | |
| DHVWWRRVPQRKEVS | 116 | Q9NUL5 | |
| KLAREIRWRLWKAHE | 161 | A6NEH8 | |
| DRRTAEWVAWRLLGK | 286 | Q9P2K2 | |
| QAELRRKWRRWHLQG | 396 | P32241 | |
| RNLLDAWRFWHKRAE | 701 | Q9NXC5 | |
| DGTARIWQFKRREWK | 386 | Q8WWQ0 | |
| GQEHRLGRWWRIKEA | 441 | O43818 | |
| RWVRANHAAIWRIIL | 306 | Q8IV42 | |
| RLRGLKRWMGDWHSQ | 366 | Q7L0X0 | |
| DHWLRRREDSGWELK | 51 | Q9BU02 | |
| THWRVAHERDELWRA | 621 | Q9H1D0 | |
| WHKLLGLWEARREAL | 1181 | Q9H254 | |
| HLAWLSDWLRQRPRV | 216 | O94813 | |
| TPEKHRARKRQAWLW | 371 | P54274 | |
| RLDTLIEWWREKNGS | 521 | Q9H0V1 | |
| RADPLRTWRWHNLLV | 36 | Q96CP7 | |
| LRRWKERETWEALAQ | 36 | Q5SQS7 | |
| GHRRKNWTERWFVLK | 221 | Q9UH65 | |
| LHPAERKTQVWRWQS | 66 | Q70YC4 | |
| EIWERLERENRGKWQ | 336 | O75800 | |
| QVRTLWHDPRNIGWK | 1091 | P35442 | |
| NDRIWLAHRWRSRAE | 236 | Q9BR11 | |
| RREDLDKLHRAAWWG | 136 | Q6S5H5 | |
| RREDLDKLHRAAWWG | 136 | A6NI47 | |
| LHCWQIWKQRIRDLT | 71 | Q96NJ3 | |
| RRIEWLSLASRRIWG | 491 | A6NCI4 | |
| RVEKHWRLIGWGQIR | 446 | P41091 | |
| GRHAAEGKWWVRKRI | 526 | Q96S06 | |
| WTQDRLHDRQRVLHW | 61 | Q9BRK3 | |
| IALNRHRLWEMVGRW | 361 | Q14957 |